Migraine Clinical Trial
Study Name: MIGRAINE STUDY
Therapy Area: Migraine
Gender and Age: Male and Female aged 18 - 55
1 in 7 people suffer from migraine.
We understand that there is a need for new treatments, and at our Manchester clinic we are currently running a clinical trial to develop a new drug for migraine sufferers.
Eligible participants will be required to attend a medical screening, a 2-night residential stay, and a follow up visit.
If you are eligible and you decide to take part, you may be helping the development of a new treatment that may help improve the quality of life for many of people.
Up to £805 plus travel will be provided or reasonable travel expenses reimbursed.
Key Inclusion Criteria
Male or female aged 18 to 55.
Diagnosed with migraines without any warning and typically suffering from 1 – 8 attacks per month.
Must be willing to comply with study restrictions and to remain at the clinic for 2 nights.
Must be in otherwise good health.
Key Exclusion Criteria
Individuals with a significant illness other than migraine.
Another current headache disorder.
You must not have smoked or used nicotine products within 3 months. This includes e-cigarettes.
Any other information
You will receive a health screen and your General Practitioner (GP) will be informed.